Seres Therapeutics Inc buy Quitte
Start price
17.08.16
/
50%
€10.03
Target price
17.02.17
€12.80
Performance (%)
-10.50%
End price
17.02.17
€8.97
Summary
This prediction ended on 17.02.17 with a price of €8.97. The price of Seres Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.50%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Seres Therapeutics Inc | -9.402% | -9.402% | -80.942% | -95.399% |
iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by Quitte for this prediction
In the thread Seres Therapeutics Inc diskutieren
hübsches Cash-Polster
und eine üble Abstrafung lassen mich hier zuversichtlich sein
(Laufzeit überschritten)